Published in Neurochem Int on June 21, 2007
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂. Pharmacol Rev (2010) 4.31
Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells. J Neurosci (2011) 2.90
TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus. Nat Neurosci (2010) 2.06
Effects of TRPV1 activation on synaptic excitation in the dentate gyrus of a mouse model of temporal lobe epilepsy. Exp Neurol (2010) 1.01
Endocannabinoid-mediated synaptic plasticity and addiction-related behavior. Neuropharmacology (2011) 0.94
TRPV1 and Endocannabinoids: Emerging Molecular Signals that Modulate Mammalian Vision. Cells (2014) 0.82
Blocking TRPV1 in nucleus accumbens inhibits persistent morphine conditioned place preference expression in rats. PLoS One (2014) 0.77
The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature (1997) 30.59
The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron (1998) 13.03
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature (1999) 10.05
Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature (2000) 7.66
Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev (1999) 7.20
A capsaicin-receptor homologue with a high threshold for noxious heat. Nature (1999) 5.85
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol (2000) 3.57
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci U S A (2002) 3.16
Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci U S A (2000) 2.87
Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. Brain Res Mol Brain Res (2005) 2.18
Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience (2006) 2.07
The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation. J Neurosci (2007) 2.07
Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. Neuropharmacology (2002) 1.75
Capsaicin regulates voltage-dependent sodium channels by altering lipid bilayer elasticity. Mol Pharmacol (2005) 1.70
[3H]Resiniferatoxin autoradiography in the CNS of wild-type and TRPV1 null mice defines TRPV1 (VR-1) protein distribution. Brain Res (2004) 1.54
Presynaptic facilitation of glutamatergic synapses to dopaminergic neurons of the rat substantia nigra by endogenous stimulation of vanilloid receptors. J Neurosci (2003) 1.41
Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro. J Physiol (2002) 1.29
Existence of capsaicin-sensitive glutamatergic terminals in rat hypothalamus. Neuroreport (1998) 1.27
Forty years in capsaicin research for sensory pharmacology and physiology. Neuropeptides (2004) 1.26
Capsaicin causes prolonged inhibition of voltage-activated calcium currents in adult rat dorsal root ganglion neurons in culture. Neuroscience (1991) 1.18
The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. Neuropharmacology (2001) 1.17
Changes in osmolality sensitize the response to capsaicin in trigeminal sensory neurons. J Neurophysiol (2007) 1.11
Specific binding of [3H]resiniferatoxin by human and rat preoptic area, locus ceruleus, medial hypothalamus, reticular formation and ventral thalamus membrane preparations. Life Sci (1996) 1.10
TRPV1 receptor mediates glutamatergic synaptic input to dorsolateral periaqueductal gray (dl-PAG) neurons. J Neurophysiol (2006) 1.07
Capsaicin desensitization of peripheral nociceptive fibres does not impair sensitivity to other noxious stimuli. Neurosci Lett (1989) 1.03
Lack of evidence for functional TRPV1 vanilloid receptors in rat hippocampal nerve terminals. Neurosci Lett (2006) 0.93
Cannabinoids inhibit the release of [3H]glutamate from rodent hippocampal synaptosomes via a novel CB1 receptor-independent action. Eur J Neurosci (2003) 0.92
Effect of capsaicin on voltage-gated currents of trigeminal neurones in cell culture and slice preparations. Acta Physiol Hung (2001) 0.79
Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci (2006) 2.81
New insights into the classification and nomenclature of cortical GABAergic interneurons. Nat Rev Neurosci (2013) 2.65
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med (2008) 2.60
Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J Neurosci (2005) 2.32
Parvalbumin-containing fast-spiking basket cells generate the field potential oscillations induced by cholinergic receptor activation in the hippocampus. J Neurosci (2010) 1.93
Fast synaptic subcortical control of hippocampal circuits. Science (2009) 1.93
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus. Nat Neurosci (2005) 1.92
Impaired and repaired inhibitory circuits in the epileptic human hippocampus. Trends Neurosci (2005) 1.82
Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures. Neuron (2003) 1.80
Laminar analysis of slow wave activity in humans. Brain (2010) 1.80
Maintaining network activity in submerged hippocampal slices: importance of oxygen supply. Eur J Neurosci (2009) 1.78
Multiple functions of endocannabinoid signaling in the brain. Annu Rev Neurosci (2012) 1.60
Synaptic currents in anatomically identified CA3 neurons during hippocampal gamma oscillations in vitro. J Neurosci (2006) 1.53
Feedforward inhibition underlies the propagation of cholinergically induced gamma oscillations from hippocampal CA3 to CA1. J Neurosci (2013) 1.52
Identification of the current generator underlying cholinergically induced gamma frequency field potential oscillations in the hippocampal CA3 region. J Physiol (2010) 1.43
Phase segregation of medial septal GABAergic neurons during hippocampal theta activity. J Neurosci (2004) 1.37
GABAergic neurons of the medial septum lead the hippocampal network during theta activity. J Neurosci (2009) 1.36
Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization. Science (2009) 1.34
Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus. J Neurosci (2008) 1.32
Differences in subthreshold resonance of hippocampal pyramidal cells and interneurons: the role of h-current and passive membrane characteristics. J Physiol (2010) 1.31
Roller Coaster Scanning reveals spontaneous triggering of dendritic spikes in CA1 interneurons. Proc Natl Acad Sci U S A (2011) 1.19
Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition. Chem Phys Lipids (2002) 1.18
Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. Neuropharmacology (2007) 1.15
Enzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminals. J Neurosci (2008) 1.14
Distinct synaptic properties of perisomatic inhibitory cell types and their different modulation by cholinergic receptor activation in the CA3 region of the mouse hippocampus. Eur J Neurosci (2010) 1.09
Hippocampal GABAergic synapses possess the molecular machinery for retrograde nitric oxide signaling. J Neurosci (2007) 1.07
Convergence of excitatory and inhibitory inputs onto CCK-containing basket cells in the CA1 area of the rat hippocampus. Eur J Neurosci (2004) 1.07
Cannabinoids attenuate hippocampal γ oscillations by suppressing excitatory synaptic input onto CA3 pyramidal neurons and fast spiking basket cells. J Physiol (2011) 1.07
Endocannabinoid transport tightly controls 2-arachidonoyl glycerol actions in the hippocampus: effects of low temperature and the transport inhibitor AM404. Eur J Neurosci (2004) 1.06
Populations of hippocampal inhibitory neurons express different levels of cytochrome c. Eur J Neurosci (2006) 1.06
Involvement of nitric oxide in depolarization-induced suppression of inhibition in hippocampal pyramidal cells during activation of cholinergic receptors. J Neurosci (2007) 1.06
The presence of pacemaker HCN channels identifies theta rhythmic GABAergic neurons in the medial septum. J Physiol (2008) 1.05
Immunocytochemically defined interneuron populations in the hippocampus of mouse strains used in transgenic technology. Hippocampus (2004) 1.05
Cell type-specific differences in chloride-regulatory mechanisms and GABA(A) receptor-mediated inhibition in rat substantia nigra. J Neurosci (2003) 1.04
Types and synaptic connections of hippocampal inhibitory neurons reciprocally connected with the medial septum. Eur J Neurosci (2008) 1.02
Post-natal development of type 1 cannabinoid receptor immunoreactivity in the rat hippocampus. Eur J Neurosci (2003) 1.00
Input-output features of anatomically identified CA3 neurons during hippocampal sharp wave/ripple oscillation in vitro. J Neurosci (2013) 1.00
The epileptic human hippocampal cornu ammonis 2 region generates spontaneous interictal-like activity in vitro. Brain (2009) 0.99
Cellular and subcellular distribution of spinophilin, a PP1 regulatory protein that bundles F-actin in dendritic spines. J Comp Neurol (2004) 0.97
Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington's disease. J Neural Transm (Vienna) (2010) 0.96
Physiological sharp wave-ripples and interictal events in vitro: what's the difference? Brain (2014) 0.96
NMDA receptors in hippocampal GABAergic synapses and their role in nitric oxide signaling. J Neurosci (2011) 0.96
Dynamic changes of CB1-receptor expression in hippocampi of epileptic mice and humans. Epilepsia (2010) 0.96
Properties of in vivo interictal spike generation in the human subiculum. Brain (2007) 0.95
Redistribution of CB1 cannabinoid receptors in the acute and chronic phases of pilocarpine-induced epilepsy. PLoS One (2011) 0.94
CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2. Neuropharmacology (2007) 0.94
The effects of cannabinoids on contextual conditioned fear in CB1 knockout and CD1 mice. Behav Pharmacol (2006) 0.92
Endocannabinoid-mediated long-term depression of afferent excitatory synapses in hippocampal pyramidal cells and GABAergic interneurons. J Neurosci (2012) 0.92
Extrinsic and local glutamatergic inputs of the rat hippocampal CA1 area differentially innervate pyramidal cells and interneurons. Hippocampus (2011) 0.92
Glutamatergic input from specific sources influences the nucleus accumbens-ventral pallidum information flow. Brain Struct Funct (2011) 0.91
Quantitative ultrastructural analysis of basket and axo-axonic cell terminals in the mouse hippocampus. Brain Struct Funct (2014) 0.90
In vivo laminar electrophysiology co-registered with histology in the hippocampus of patients with temporal lobe epilepsy. Exp Neurol (2004) 0.90
Loss and reorganization of calretinin-containing interneurons in the epileptic human hippocampus. Brain (2010) 0.89
Neuroligin 2 is expressed in synapses established by cholinergic cells in the mouse brain. PLoS One (2013) 0.89
Excitement reduces inhibition via endocannabinoids. Neuron (2003) 0.87
Anatomically heterogeneous populations of CB1 cannabinoid receptor-expressing interneurons in the CA3 region of the hippocampus show homogeneous input-output characteristics. Hippocampus (2014) 0.85
Complex propagation patterns characterize human cortical activity during slow-wave sleep. J Neurosci (2011) 0.83
GABAB and CB1 cannabinoid receptor expression identifies two types of septal cholinergic neurons. Eur J Neurosci (2005) 0.83
NMDA receptors in GABAergic synapses during postnatal development. PLoS One (2012) 0.81
Molecular architecture of the cannabinoid signaling system in the core of the nucleus accumbens. Ideggyogy Sz (2007) 0.81
Distinct properties of two major excitatory inputs to hippocampal pyramidal cells: a computational study. Eur J Neurosci (2005) 0.81
Different input and output properties characterize parvalbumin-positive basket and Axo-axonic cells in the hippocampal CA3 subfield. Hippocampus (2013) 0.80
Nitric oxide signaling modulates synaptic transmission during early postnatal development. Cereb Cortex (2011) 0.79
Discovery research in neuropsychiatry - anxiety, depression and schizophrenia in focus. Editorial. Neurosci Biobehav Rev (2013) 0.79
Alkamides and a neolignan from Echinacea purpurea roots and the interaction of alkamides with G-protein-coupled cannabinoid receptors. Phytochemistry (2011) 0.78
DAG-sensitive and Ca(2+) permeable TRPC6 channels are expressed in dentate granule cells and interneurons in the hippocampal formation. Hippocampus (2012) 0.77
New silver-gold intensification method of diaminobenzidine for double-labeling immunoelectron microscopy. J Histochem Cytochem (2011) 0.76
The effects of an Echinacea preparation on synaptic transmission and the firing properties of CA1 pyramidal cells in the hippocampus. Phytother Res (2011) 0.76
The anxiolytic potential and psychotropic side effects of an echinacea preparation in laboratory animals and healthy volunteers. Phytother Res (2012) 0.76
In vivo SPECT and ex vivo autoradiographic brain imaging of the novel selective CB1 receptor antagonist radioligand [125I]SD7015 in CB1 knock-out and wildtype mouse. Brain Res Bull (2013) 0.75
European Brain Council: partnership to promote European and national brain research. Trends Neurosci (2006) 0.75
Possible role of fat tissue in the pharmacokinetics of Dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides after oral administration of Echinacea angustifolia extract in rats. Nat Prod Commun (2014) 0.75
Corrigendum: Tonic endocannabinoid-mediated modulation of GABA release is independent of the CB1 content of axon terminals. Nat Commun (2015) 0.75